Hereditary Angioedema Market, Global Outlook and Forecast 2022-2028

March 2022 | 71 pages | ID: H1129FF4F3BBEN
Market Monitor Global

Abstracts

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.

This report contains market size and forecasts of Hereditary Angioedema in global, including the following market information:

Global Hereditary Angioedema Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hereditary Angioedema Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Hereditary Angioedema companies in 2021 (%)

The global Hereditary Angioedema market was valued at 1704.7 million in 2021 and is projected to reach US$ 2731.4 million by 2028, at a CAGR of 7.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

C1 Esterase Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hereditary Angioedema include Pharming Group NV, Takeda, CSL Limited, iBio Inc., BioCryst Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hereditary Angioedema manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hereditary Angioedema Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Hereditary Angioedema Market Segment Percentages, by Type, 2021 (%)

• C1 Esterase Inhibitor
• Kallikrein Inhibitor
• Selective Bradykinin B2 Receptor Antagonist

Global Hereditary Angioedema Market, by Distribution Channel, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Hereditary Angioedema Market Segment Percentages, by Distribution Channel, 2021 (%)

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Hereditary Angioedema Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Hereditary Angioedema Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hereditary Angioedema revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hereditary Angioedema revenues share in global market, 2021 (%)

Key companies Hereditary Angioedema sales in global market, 2017-2022 (Estimated), (MT)

Key companies Hereditary Angioedema sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pharming Group NV
• Takeda
• CSL Limited
• iBio Inc.
• BioCryst Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hereditary Angioedema Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Distribution Channel
1.3 Global Hereditary Angioedema Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEREDITARY ANGIOEDEMA OVERALL MARKET SIZE

2.1 Global Hereditary Angioedema Market Size: 2021 VS 2028
2.2 Global Hereditary Angioedema Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hereditary Angioedema Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Hereditary Angioedema Players in Global Market
3.2 Top Global Hereditary Angioedema Companies Ranked by Revenue
3.3 Global Hereditary Angioedema Revenue by Companies
3.4 Global Hereditary Angioedema Sales by Companies
3.5 Global Hereditary Angioedema Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hereditary Angioedema Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hereditary Angioedema Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hereditary Angioedema Players in Global Market
  3.8.1 List of Global Tier 1 Hereditary Angioedema Companies
  3.8.2 List of Global Tier 2 and Tier 3 Hereditary Angioedema Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Hereditary Angioedema Market Size Markets, 2021 & 2028
  4.1.2 C1 Esterase Inhibitor
  4.1.3 Kallikrein Inhibitor
  4.1.4 Selective Bradykinin B2 Receptor Antagonist
4.2 By Type - Global Hereditary Angioedema Revenue & Forecasts
  4.2.1 By Type - Global Hereditary Angioedema Revenue, 2017-2022
  4.2.2 By Type - Global Hereditary Angioedema Revenue, 2023-2028
  4.2.3 By Type - Global Hereditary Angioedema Revenue Market Share, 2017-2028
4.3 By Type - Global Hereditary Angioedema Sales & Forecasts
  4.3.1 By Type - Global Hereditary Angioedema Sales, 2017-2022
  4.3.2 By Type - Global Hereditary Angioedema Sales, 2023-2028
  4.3.3 By Type - Global Hereditary Angioedema Sales Market Share, 2017-2028
4.4 By Type - Global Hereditary Angioedema Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY DISTRIBUTION CHANNEL

5.1 Overview
  5.1.1 By Distribution Channel - Global Hereditary Angioedema Market Size, 2021 & 2028
  5.1.2 Retail Pharmacies
  5.1.3 Hospital Pharmacies
  5.1.4 Online Pharmacies
5.2 By Distribution Channel - Global Hereditary Angioedema Revenue & Forecasts
  5.2.1 By Distribution Channel - Global Hereditary Angioedema Revenue, 2017-2022
  5.2.2 By Distribution Channel - Global Hereditary Angioedema Revenue, 2023-2028
  5.2.3 By Distribution Channel - Global Hereditary Angioedema Revenue Market Share, 2017-2028
5.3 By Distribution Channel - Global Hereditary Angioedema Sales & Forecasts
  5.3.1 By Distribution Channel - Global Hereditary Angioedema Sales, 2017-2022
  5.3.2 By Distribution Channel - Global Hereditary Angioedema Sales, 2023-2028
  5.3.3 By Distribution Channel - Global Hereditary Angioedema Sales Market Share, 2017-2028
5.4 By Distribution Channel - Global Hereditary Angioedema Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hereditary Angioedema Market Size, 2021 & 2028
6.2 By Region - Global Hereditary Angioedema Revenue & Forecasts
  6.2.1 By Region - Global Hereditary Angioedema Revenue, 2017-2022
  6.2.2 By Region - Global Hereditary Angioedema Revenue, 2023-2028
  6.2.3 By Region - Global Hereditary Angioedema Revenue Market Share, 2017-2028
6.3 By Region - Global Hereditary Angioedema Sales & Forecasts
  6.3.1 By Region - Global Hereditary Angioedema Sales, 2017-2022
  6.3.2 By Region - Global Hereditary Angioedema Sales, 2023-2028
  6.3.3 By Region - Global Hereditary Angioedema Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Hereditary Angioedema Revenue, 2017-2028
  6.4.2 By Country - North America Hereditary Angioedema Sales, 2017-2028
  6.4.3 US Hereditary Angioedema Market Size, 2017-2028
  6.4.4 Canada Hereditary Angioedema Market Size, 2017-2028
  6.4.5 Mexico Hereditary Angioedema Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Hereditary Angioedema Revenue, 2017-2028
  6.5.2 By Country - Europe Hereditary Angioedema Sales, 2017-2028
  6.5.3 Germany Hereditary Angioedema Market Size, 2017-2028
  6.5.4 France Hereditary Angioedema Market Size, 2017-2028
  6.5.5 U.K. Hereditary Angioedema Market Size, 2017-2028
  6.5.6 Italy Hereditary Angioedema Market Size, 2017-2028
  6.5.7 Russia Hereditary Angioedema Market Size, 2017-2028
  6.5.8 Nordic Countries Hereditary Angioedema Market Size, 2017-2028
  6.5.9 Benelux Hereditary Angioedema Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Hereditary Angioedema Revenue, 2017-2028
  6.6.2 By Region - Asia Hereditary Angioedema Sales, 2017-2028
  6.6.3 China Hereditary Angioedema Market Size, 2017-2028
  6.6.4 Japan Hereditary Angioedema Market Size, 2017-2028
  6.6.5 South Korea Hereditary Angioedema Market Size, 2017-2028
  6.6.6 Southeast Asia Hereditary Angioedema Market Size, 2017-2028
  6.6.7 India Hereditary Angioedema Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Hereditary Angioedema Revenue, 2017-2028
  6.7.2 By Country - South America Hereditary Angioedema Sales, 2017-2028
  6.7.3 Brazil Hereditary Angioedema Market Size, 2017-2028
  6.7.4 Argentina Hereditary Angioedema Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Hereditary Angioedema Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Hereditary Angioedema Sales, 2017-2028
  6.8.3 Turkey Hereditary Angioedema Market Size, 2017-2028
  6.8.4 Israel Hereditary Angioedema Market Size, 2017-2028
  6.8.5 Saudi Arabia Hereditary Angioedema Market Size, 2017-2028
  6.8.6 UAE Hereditary Angioedema Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Pharming Group NV
  7.1.1 Pharming Group NV Corporate Summary
  7.1.2 Pharming Group NV Business Overview
  7.1.3 Pharming Group NV Hereditary Angioedema Major Product Offerings
  7.1.4 Pharming Group NV Hereditary Angioedema Sales and Revenue in Global (2017-2022)
  7.1.5 Pharming Group NV Key News
7.2 Takeda
  7.2.1 Takeda Corporate Summary
  7.2.2 Takeda Business Overview
  7.2.3 Takeda Hereditary Angioedema Major Product Offerings
  7.2.4 Takeda Hereditary Angioedema Sales and Revenue in Global (2017-2022)
  7.2.5 Takeda Key News
7.3 CSL Limited
  7.3.1 CSL Limited Corporate Summary
  7.3.2 CSL Limited Business Overview
  7.3.3 CSL Limited Hereditary Angioedema Major Product Offerings
  7.3.4 CSL Limited Hereditary Angioedema Sales and Revenue in Global (2017-2022)
  7.3.5 CSL Limited Key News
7.4 iBio Inc.
  7.4.1 iBio Inc. Corporate Summary
  7.4.2 iBio Inc. Business Overview
  7.4.3 iBio Inc. Hereditary Angioedema Major Product Offerings
  7.4.4 iBio Inc. Hereditary Angioedema Sales and Revenue in Global (2017-2022)
  7.4.5 iBio Inc. Key News
7.5 BioCryst Pharmaceuticals, Inc.
  7.5.1 BioCryst Pharmaceuticals, Inc. Corporate Summary
  7.5.2 BioCryst Pharmaceuticals, Inc. Business Overview
  7.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Major Product Offerings
  7.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales and Revenue in Global (2017-2022)
  7.5.5 BioCryst Pharmaceuticals, Inc. Key News
7.6 Ionis Pharmaceuticals, Inc.
  7.6.1 Ionis Pharmaceuticals, Inc. Corporate Summary
  7.6.2 Ionis Pharmaceuticals, Inc. Business Overview
  7.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Major Product Offerings
  7.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales and Revenue in Global (2017-2022)
  7.6.5 Ionis Pharmaceuticals, Inc. Key News

8 GLOBAL HEREDITARY ANGIOEDEMA PRODUCTION CAPACITY, ANALYSIS

8.1 Global Hereditary Angioedema Production Capacity, 2017-2028
8.2 Hereditary Angioedema Production Capacity of Key Manufacturers in Global Market
8.3 Global Hereditary Angioedema Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HEREDITARY ANGIOEDEMA SUPPLY CHAIN ANALYSIS

10.1 Hereditary Angioedema Industry Value Chain
10.2 Hereditary Angioedema Upstream Market
10.3 Hereditary Angioedema Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Hereditary Angioedema Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Hereditary Angioedema in Global Market
Table 2. Top Hereditary Angioedema Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Hereditary Angioedema Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Hereditary Angioedema Revenue Share by Companies, 2017-2022
Table 5. Global Hereditary Angioedema Sales by Companies, (MT), 2017-2022
Table 6. Global Hereditary Angioedema Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Hereditary Angioedema Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Hereditary Angioedema Product Type
Table 9. List of Global Tier 1 Hereditary Angioedema Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hereditary Angioedema Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hereditary Angioedema Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Hereditary Angioedema Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Hereditary Angioedema Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Hereditary Angioedema Sales (MT), 2017-2022
Table 15. By Type - Global Hereditary Angioedema Sales (MT), 2023-2028
Table 16. By Distribution Channel – Global Hereditary Angioedema Revenue, (US$, Mn), 2021 & 2028
Table 17. By Distribution Channel - Global Hereditary Angioedema Revenue (US$, Mn), 2017-2022
Table 18. By Distribution Channel - Global Hereditary Angioedema Revenue (US$, Mn), 2023-2028
Table 19. By Distribution Channel - Global Hereditary Angioedema Sales (MT), 2017-2022
Table 20. By Distribution Channel - Global Hereditary Angioedema Sales (MT), 2023-2028
Table 21. By Region – Global Hereditary Angioedema Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Hereditary Angioedema Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Hereditary Angioedema Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Hereditary Angioedema Sales (MT), 2017-2022
Table 25. By Region - Global Hereditary Angioedema Sales (MT), 2023-2028
Table 26. By Country - North America Hereditary Angioedema Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Hereditary Angioedema Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Hereditary Angioedema Sales, (MT), 2017-2022
Table 29. By Country - North America Hereditary Angioedema Sales, (MT), 2023-2028
Table 30. By Country - Europe Hereditary Angioedema Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Hereditary Angioedema Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Hereditary Angioedema Sales, (MT), 2017-2022
Table 33. By Country - Europe Hereditary Angioedema Sales, (MT), 2023-2028
Table 34. By Region - Asia Hereditary Angioedema Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Hereditary Angioedema Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Hereditary Angioedema Sales, (MT), 2017-2022
Table 37. By Region - Asia Hereditary Angioedema Sales, (MT), 2023-2028
Table 38. By Country - South America Hereditary Angioedema Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Hereditary Angioedema Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Hereditary Angioedema Sales, (MT), 2017-2022
Table 41. By Country - South America Hereditary Angioedema Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Hereditary Angioedema Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Hereditary Angioedema Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Hereditary Angioedema Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Hereditary Angioedema Sales, (MT), 2023-2028
Table 46. Pharming Group NV Corporate Summary
Table 47. Pharming Group NV Hereditary Angioedema Product Offerings
Table 48. Pharming Group NV Hereditary Angioedema Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Takeda Corporate Summary
Table 50. Takeda Hereditary Angioedema Product Offerings
Table 51. Takeda Hereditary Angioedema Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. CSL Limited Corporate Summary
Table 53. CSL Limited Hereditary Angioedema Product Offerings
Table 54. CSL Limited Hereditary Angioedema Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. iBio Inc. Corporate Summary
Table 56. iBio Inc. Hereditary Angioedema Product Offerings
Table 57. iBio Inc. Hereditary Angioedema Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. BioCryst Pharmaceuticals, Inc. Corporate Summary
Table 59. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Offerings
Table 60. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Ionis Pharmaceuticals, Inc. Corporate Summary
Table 62. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Offerings
Table 63. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Hereditary Angioedema Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 65. Global Hereditary Angioedema Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Hereditary Angioedema Production by Region, 2017-2022 (MT)
Table 67. Global Hereditary Angioedema Production by Region, 2023-2028 (MT)
Table 68. Hereditary Angioedema Market Opportunities & Trends in Global Market
Table 69. Hereditary Angioedema Market Drivers in Global Market
Table 70. Hereditary Angioedema Market Restraints in Global Market
Table 71. Hereditary Angioedema Raw Materials
Table 72. Hereditary Angioedema Raw Materials Suppliers in Global Market
Table 73. Typical Hereditary Angioedema Downstream
Table 74. Hereditary Angioedema Downstream Clients in Global Market
Table 75. Hereditary Angioedema Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Hereditary Angioedema Segment by Type
Figure 2. Hereditary Angioedema Segment by Distribution Channel
Figure 3. Global Hereditary Angioedema Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hereditary Angioedema Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hereditary Angioedema Revenue, 2017-2028 (US$, Mn)
Figure 7. Hereditary Angioedema Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Hereditary Angioedema Revenue in 2021
Figure 9. By Type - Global Hereditary Angioedema Sales Market Share, 2017-2028
Figure 10. By Type - Global Hereditary Angioedema Revenue Market Share, 2017-2028
Figure 11. By Type - Global Hereditary Angioedema Price (USD/Kg), 2017-2028
Figure 12. By Distribution Channel - Global Hereditary Angioedema Sales Market Share, 2017-2028
Figure 13. By Distribution Channel - Global Hereditary Angioedema Revenue Market Share, 2017-2028
Figure 14. By Distribution Channel - Global Hereditary Angioedema Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Hereditary Angioedema Sales Market Share, 2017-2028
Figure 16. By Region - Global Hereditary Angioedema Revenue Market Share, 2017-2028
Figure 17. By Country - North America Hereditary Angioedema Revenue Market Share, 2017-2028
Figure 18. By Country - North America Hereditary Angioedema Sales Market Share, 2017-2028
Figure 19. US Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Hereditary Angioedema Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Hereditary Angioedema Sales Market Share, 2017-2028
Figure 24. Germany Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 25. France Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Hereditary Angioedema Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Hereditary Angioedema Sales Market Share, 2017-2028
Figure 33. China Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 37. India Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Hereditary Angioedema Revenue Market Share, 2017-2028
Figure 39. By Country - South America Hereditary Angioedema Sales Market Share, 2017-2028
Figure 40. Brazil Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Hereditary Angioedema Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Hereditary Angioedema Sales Market Share, 2017-2028
Figure 44. Turkey Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Hereditary Angioedema Revenue, (US$, Mn), 2017-2028
Figure 48. Global Hereditary Angioedema Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Hereditary Angioedema by Region, 2021 VS 2028
Figure 50. Hereditary Angioedema Industry Value Chain
Figure 51. Marketing Channels